One World Products (OWPC) 10-Q 5 Jul 23 2023 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2023	Jul. 03, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2023
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	000-56151
Entity Registrant Name	ONE WORLD PRODUCTS, INC.
Entity Central Index Key	0001622244
Entity Tax Identification Number	61-1744826
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	6605 Grand Montecito Pkwy
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89149
City Area Code	(800)
Local Phone Number	605-3210
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		73,369,574

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 84,709	$ 11,016
Accounts receivable	10,682	12,355
Inventory	279,190	54,153
Other current assets	73,296	45,943
Total current assets	447,877	123,467
Other assets	186,950	179,927
Right-of-use assets	403,727	425,969
Security deposits	50,411	1,449,808
Fixed assets, net	2,385,138	988,536
Total Assets	3,474,103	3,167,707
Current liabilities:
Accounts payable	747,723	798,067
Accrued expenses	1,119,725	948,458
Deferred revenues	10,114	11,808
Dividends payable	150,616	137,843
Current portion of lease liabilities	88,612	86,235
Convertible notes payable	750,000	750,000
Notes payable, related parties, current maturities	151,277	145,524
Total current liabilities	3,117,567	2,977,435
Long-term lease liability	318,556	341,680
Notes payable, related parties, long-term portion	700,000	700,000
Total Liabilities	4,336,123	4,219,115
Stockholders’ Equity (Deficit):
Preferred stock, $0.001 par value, 9,200,000 shares authorized; no shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively
Common stock, $0.001 par value, 300,000,000 shares authorized; 70,202,907 and 67,202,907 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	70,203	67,203
Additional paid-in capital	17,445,960	17,123,603
Accumulated other comprehensive income (loss)	134,270	(50,699)
Accumulated (deficit)	(23,492,303)	(22,976,365)
Total Stockholders’ Equity (Deficit)	(5,841,870)	(5,836,258)
Total Liabilities and Stockholders’ Equity (Deficit)	3,474,103	3,167,707
Series A Convertible Preferred Stock [Member]
Current liabilities:
Convertible preferred stock value	897,330	702,330
Series B Convertible Preferred Stock [Member]
Current liabilities:
Convertible preferred stock value	4,082,520	4,082,520
Nonrelated Party [Member]
Current liabilities:
Notes payable, related parties, current maturities	151,277	145,524
Notes payable, related parties, long-term portion	700,000	700,000
Related Party [Member]
Current liabilities:
Notes payable, related parties, current maturities	99,500	99,500
Notes payable, related parties, long-term portion	$ 200,000	$ 200,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	9,200,000	9,200,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	70,202,907	67,202,907
Common stock, shares outstanding	70,202,907	67,202,907
Series A Convertible Preferred Stock [Member]
Temporary equity, par value	$ 0.001	$ 0.001
Temporary equity, shares authorized	500,000	500,000
Temporary equity, shares issued	89,733	70,233
Temporary equity, shares outstanding	89,733	70,233
Preferred stock, shares authorized	10,000,000
Series B Convertible Preferred Stock [Member]
Temporary equity, par value	$ 0.001	$ 0.001
Temporary equity, shares authorized	300,000	300,000
Temporary equity, shares issued	272,168	272,168
Temporary equity, shares outstanding	272,168	272,168

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenues	$ 2,101	$ 10,147
Cost of goods sold	967	9,956
Gross profit	1,134	191
Operating expenses:
General and administrative	347,297	381,383
Professional fees	103,848	171,050
Depreciation expense	7,857	12,485
Total operating expenses	459,002	564,918
Operating loss	(457,868)	(564,727)
Other income (expense):
Gain on early extinguishment of debt		121,372
Interest income		41
Interest expense	(58,070)	(166,192)
Total other expense	(58,070)	(44,779)
Net loss	(515,938)	(609,506)
Other comprehensive loss:
Gain on foreign currency translation	184,969	16,804
Net other comprehensive loss	(330,969)	(592,702)
Series A convertible preferred stock declared ($0.60 per share)	(12,773)	(10,258)
Net loss attributable to common shareholders	$ (343,742)	$ (602,960)
Weighted average number of common shares outstanding - basic and diluted	68,702,907	65,605,389
Net loss per share - basic and diluted	$ (0.01)	$ (0.01)
Dividends declared per share of common stock	$ 0	$ 0

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2023	Mar. 31, 2022
Series A Convertible Preferred Stock [Member]
Purchase price per share	$ 0.60	$ 0.60

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Preferred Stock [Member] Series A Convertible Preferred Stock [Member]	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Subscriptions Payable [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2021	$ 652,330	$ 3,577,515	$ 65,600	$ 16,843,656	$ 21,725	$ (64,347)	$ (19,916,888)	$ (3,050,254)
Balance, shares at Dec. 31, 2021	65,233	238,501	65,599,565
Amortization of common stock options issued for services				41,114				41,114
Series A convertible preferred stock dividend declared ($0.60 per share)				(10,258)				(10,258)
Gain on foreign currency translation						16,804		16,804
Net loss							(609,506)	(609,506)
Common stock issued for services			$ 262	21,463	(21,725)
Common stock issued for services, shares			262,066
Balance at Mar. 31, 2022	$ 652,330	$ 3,577,515	$ 65,862	16,895,975		(47,543)	(20,526,394)	(3,612,100)
Balance, shares at Mar. 31, 2022	65,233	238,501	65,861,631
Balance at Dec. 31, 2022	$ 702,330	$ 4,082,520	$ 67,203	17,123,603		(50,699)	(22,976,365)	(5,836,258)
Balance, shares at Dec. 31, 2022	70,233	272,168	67,202,907
Series A Convertible Preferred Stock sold for cash	$ 150,000
Series A convertible preferred stock sold for cash, shares	15,000
Series A Convertible Preferred Stock issued for services	$ 45,000
Series A Convertible Preferred Stock issued for services, shares	4,500
Common stock sold for cash			$ 3,000	297,000				300,000
Common stock sold for cash, shares			3,000,000
Amortization of common stock options issued for services				38,130				38,130
Series A convertible preferred stock dividend declared ($0.60 per share)				(12,773)				(12,773)
Gain on foreign currency translation						184,969		184,969
Net loss							(515,938)	(515,938)
Balance at Mar. 31, 2023	$ 897,330	$ 4,082,520	$ 70,203	$ 17,445,960		$ 134,270	$ (23,492,303)	$ (5,841,870)
Balance, shares at Mar. 31, 2023	89,733	272,168	70,202,907

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Series A Convertible Preferred Stock [Member]
Share issued price per share	$ 0.60	$ 0.60

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities
Net loss	$ (515,938)	$ (609,506)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	7,857	12,485
Gain on early extinguishment of debt		(121,372)
Amortization of debt discounts		142,849
Series A preferred stock issued for services	45,000
Stock options issued for services	38,130	41,114
Decrease (increase) in assets:
Accounts receivable	1,673	(9,469)
Inventory	(225,037)	(94,163)
Other current assets	(27,353)	91,019
Other assets	(7,023)
Right-of-use assets	22,242	33,430
Security deposits	(16)	(291,679)
Increase (decrease) in liabilities:
Accounts payable	(50,344)	93,596
Accrued expenses	171,267	89,690
Deferred revenues	(1,694)	908
Lease liability	(20,747)	(26,497)
Net cash used in operating activities	(561,983)	(647,595)
Cash flows from investing activities
Purchase of fixed assets	(5,046)	(3,482)
Net cash used in investing activities	(5,046)	(3,482)
Cash flows from financing activities
Proceeds from notes payable		600,000
Proceeds from sale of preferred and common stock	450,000
Net cash provided by financing activities	450,000	600,000
Effect of exchange rate changes on cash	190,722	16,804
Net increase (decrease) in cash	73,693	(34,273)
Cash - beginning	11,016	119,678
Cash - ending	84,709	85,405
Supplemental disclosures:
Interest paid	22,192	15,694
Income taxes paid
Non-cash investing and financing transactions:
Dividends payable	$ 12,773	$ 10,258

Nature of Business and Signific

Nature of Business and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Nature of Business and Significant Accounting Policies	Note 1 – Nature of Business and Significant Accounting Policies Nature of Business One World Products, Inc. (the “Company,” “we,” “our” or “us”) was incorporated in Nevada on September 2, 2014. On February 21, 2019, we entered into an Agreement and Plan of Merger with OWP Merger Subsidiary, Inc., our wholly-owned subsidiary, and OWP Ventures, Inc. (“OWP Ventures”), which is the parent company of One World Pharma SAS, a Colombian company (“OWP Colombia”). Pursuant to the Merger Agreement, we acquired OWP Ventures (and indirectly, OWP Colombia) by the merger of OWP Merger Subsidiary with and into OWP Ventures, with OWP Ventures being the surviving entity as our wholly-owned subsidiary (the “Merger”). As a result of the Merger (a) holders of the outstanding capital stock of OWP Ventures received an aggregate of 39,475,398 825,000 0.50 825,000 0.50 300,000 0.424 875,000 n November 23, 2021, the Company changed its name to One World Products, Inc. through the merger of One World Products, Inc., a recently formed Nevada corporation wholly-owned by the Company, with and into the Company (the “Name Change Merger”) pursuant to the applicable provisions of the Nevada Revised Statutes (“NRS”). As permitted by the NRS, the articles of merger filed with the Secretary of State of the state of Nevada to effect the Name Change Merger amended Article I of the Company’s Articles of Incorporation to change the Company’s name to “One World Products, Inc.” The Name Change Merger was effected solely to effect the change of the Company’s name, and had no effect on the Company’s officers, directors, operations, assets or liabilities. OWP Ventures is a holding company formed in Delaware on March 27, 2018 to enter and support the cannabis industry, and on May 30, 2018, it acquired OWP Colombia. OWP Colombia is a licensed cannabis cultivation, production and distribution (export) company located in Popayán, Colombia (nearest major city is Cali). We plan to be a producer of raw cannabis and hemp plant ingredients for both medical and industrial uses across the globe. We have received licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific and industrial purposes. Specifically, we are one of the few companies in Colombia to receive all four licenses, including seed use, cultivation of non-psychoactive cannabis, cultivation of psychoactive cannabis, and manufacturing allowing for extraction and export. Currently, we own approximately 30 acres and have a covered greenhouse built specifically to cultivate high-grade cannabis and hemp. In addition, we have entered into agreements with local farming co-operatives that include small farmers and indigenous tribe members, under which they will cultivate cannabis on up to approximately 140 acres of land using our seeds and propagation techniques, and sell their harvested products to us on an exclusive basis. We began harvesting cannabis in the first quarter of 2019 for the purpose of further research and development activities, quality control testing and extraction. We have been generating revenue from the sale of our seeds since the second quarter of 2020. During the first quarter of 2022, we made payments of approximately $ 1,400,000 5 Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and the rules of the Securities and Exchange Commission (SEC). Intercompany accounts and transactions have been eliminated. The unaudited condensed consolidated financial statements of the Company and the accompanying notes included in this Quarterly Report on Form 10-Q are unaudited. In the opinion of management, all adjustments necessary for a fair presentation of the Condensed Consolidated Financial Statements have been included. Such adjustments are of a normal, recurring nature. The Condensed Consolidated Financial Statements, and the accompanying notes, are prepared in accordance with GAAP and do not contain certain information included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The interim Condensed Consolidated Financial Statements should be read in conjunction with that Annual Report on Form 10-K. Results for the interim periods presented are not necessarily indicative of the results that might be expected for the entire fiscal year. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) Principles of Consolidation The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at March 31, 2023: Schedule of Common Control and Ownership Interest State of Name of Entity Incorporation Relationship One World Products, Inc. (1) Nevada Parent OWP Ventures, Inc. (2) Delaware Subsidiary One World Pharma S.A.S (3) Colombia Subsidiary Colombian Hope, S.A.S (4) Colombia Subsidiary Agrobase, S.A.S. (5) Colombia Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc. (3) Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogotá on July 18, 2017. Its headquarters are located in Bogotá. (4) Wholly-owned subsidiary of OWP Ventures, Inc., acquired on November 19, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. (5) Wholly-owned subsidiary of OWP Ventures, Inc., formed on September 12, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. The Company’s headquarters are located in Las Vegas, Nevada and substantially all of its production efforts are within Popayán, Colombia. Reclassifications Certain reclassifications have been made to the prior years’ financial statements to conform to current year presentation. These reclassifications had no effect on previously reported results of operations or retained earnings. Foreign Currency Translation The functional currency of the Company is Columbian Peso (COP). The Company has maintained its financial statements using the functional currency, and translated those financial statements to the US Dollar (USD) throughout this report. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income (loss) for the respective periods. Comprehensive Income The Company has adopted the Financial Accounting Standards Boards (“FASB”) Accounting Standards Codification (“ASC”) 220, Reporting Comprehensive Income, which establishes standards for reporting and displaying comprehensive income, its components, and accumulated balances in a full-set of general-purpose financial statements. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) Segment Reporting ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations. Fair Value of Financial Instruments The Company discloses the fair value of certain assets and liabilities in accordance with ASC 820 – Fair Value Measurement and Disclosures (ASC 820). Under ASC 820-10-05, the FASB establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. This Statement reaffirms that fair value is the relevant measurement attribute. The adoption of this standard did not have a material effect on the Company’s financial statements as reflected herein. The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses reported on the balance sheets are estimated by management to approximate fair value primarily due to the short-term nature of the instruments. Cash in Excess of FDIC Insured Limits The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $ 250,000 not Revenue Recognition The Company recognizes revenue in accordance with ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. The Company’s sales to date have primarily consisted of the sale of seeds. These sales include multi-element arrangements whereby the Company collects 50% of the sale upon delivery of the sales, and the remaining 50% upon the completion of the harvest, whether the seeds result in a successful crop, or not. In addition, the Company has a right of first refusal to purchase products resulting from the harvest. At March 31, 2023, the Company had $ 10,114 5,923 Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our cannabis products consist of cannabis flower grown in-house, along with produced extracts. Stock-Based Compensation The Company accounts for equity instruments issued to employees and non-employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance. Basic and Diluted Loss Per Share The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the periods presented, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements upon adoption. In October 2021, the FASB issued ASU , Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, The adoption of ASU 2021-08 did not have a material impact on the Company’s financial statements or related disclosures. In May 2021, the FASB issued ASU No. 2021-04, Earnings Per Share Debt – Modifications and Extinguishments Compensation and Derivatives and Hedging – Contracts in Entity’s Own Equity Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity Classified Written Call Options In March 2020, the FASB issued ASU 2020-04 establishing Topic 848, Reference Rate Reform In August 2020, the FASB issued ASU No. 2020-06, Debt–Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging–Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if converted method. The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2021, with early adoption permitted. The adoption of ASU 2020-06 has not had a material impact on the Company’s financial statements or related disclosures. No other new accounting pronouncements, issued or effective during the period ended March 31, 2023, have had or are expected to have a significant impact on the Company’s financial statements.

Going Concern

Going Concern	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 2 – Going Concern As shown in the accompanying condensed consolidated financial statements as of March 31, 2023, our balance of cash on hand was $ 84,709 2,669,690 23,492,303 In the event sales do not materialize at the expected rates, management would seek additional financing and would attempt to conserve cash by further reducing expenses. There can be no assurance that we will be successful in achieving these objectives; therefore, without sufficient financing it would be unlikely for the Company to continue as a going concern. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of any uncertainty as to the Company’s ability to continue as a going concern. The condensed consolidated financial statements also do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern. Our ability to scale production and distribution capabilities and further increase the value of our brands, is largely dependent on our success in raising additional capital. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2023
Investments, All Other Investments [Abstract]
Fair Value of Financial Instruments	Note 3 – Fair Value of Financial Instruments Under FASB ASC 820-10-5, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under GAAP, certain assets and liabilities must be measured at fair value, and FASB ASC 820-10-50 details the disclosures that are required for items measured at fair value. The Company has certain financial instruments that must be measured under the new fair value standard. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows: Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability. The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheet as of March 31, 2023 and December 31, 2022, respectively: Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis Level 1 Level 2 Level 3 Fair Value Measurements at March 31, 2023 Level 1 Level 2 Level 3 Assets Cash $ 84,709 $ - $ - Right-of-use asset - - 403,727 Total assets 84,709 - 403,727 Liabilities Lease liabilities - - 407,168 Convertible notes payable - 750,000 - Notes payable - 851,277 - Notes payable, related parties - 299,500 - Total liabilities - (1,900,777 ) (407,168 ) Total assets and liabilities $ 84,709 $ (1,900,777 ) $ (3,441 ) Level 1 Level 2 Level 3 Fair Value Measurements at December 31, 2022 Level 1 Level 2 Level 3 Assets Cash $ 11,016 $ - $ - Right-of-use asset - - 425,969 Total assets 11,016 - 425,969 Liabilities Lease liabilities - 427,915 Convertible notes payable - 750,000 - Notes payable - 845,524 - Notes payable, related parties - 299,500 - Total liabilities - (1,895,024 ) (427,915 ) Total assets and liabilities $ 11,016 $ (1,895,024 ) $ (1,946 ) There were no transfers of financial assets or liabilities between Level 1, Level 2 and Level 3 inputs for the three months ended March 31, 2023 or the year ended December 31, 2022. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Inventory

Inventory	3 Months Ended
	Mar. 31, 2023
Inventory Disclosure [Abstract]
Inventory	Note 4 – Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our cannabis products consist of cannabis flower grown in-house, along with produced extracts. Inventory consisted of the following at March 31, 2023 and December 31, 2022, respectively. Schedule of Inventory March 31, December 31, 2023 2022 Raw materials $ 19,215 $ 18,580 Work in progress 37,059 1,464 Finished goods 271,513 80,858 Inventory gross 327,787 100,902 Less obsolescence (48,597 ) (46,749 ) Total inventory $ 279,190 $ 54,153

Other Current Assets

Other Current Assets	3 Months Ended
	Mar. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Current Assets	Note 5 – Other Current Assets Other current assets included the following as of March 31, 2023 and December 31, 2022, respectively: Schedule of Other Current Assets March 31, December 31, 2023 2022 Prepaid expenses $ 67,373 $ 39,288 Deferred cost of goods sold 5,923 6,655 Total $ 73,296 $ 45,943

Other Assets

Other Assets	3 Months Ended
	Mar. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets	Note 6 – Other Assets Other assets consist entirely of VAT receivables in the amounts of $ 186,950 179,927

Security Deposits

Security Deposits	3 Months Ended
	Mar. 31, 2023
Security Deposits
Security Deposits	Note 7 – Security Deposits Security deposits included the following as of March 31, 2023 and December 31, 2022, respectively: Schedule of Security Deposits March 31, December 31, 2023 2022 Refundable deposit on equipment purchase $ 50,000 $ 50,000 Down payment on distillation equipment - 1,399,413 Security deposits on leases held in Colombia 411 395 Security deposits $ 50,411 $ 1,449,808 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Fixed Assets

Fixed Assets	3 Months Ended
	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Fixed Assets	Note 8 – Fixed Assets Fixed assets consist of the following at March 31, 2023 and December 31, 2022, respectively: Schedule of Fixed Assets March 31, December 31, 2023 2022 Land $ 138,248 $ 138,248 Buildings 473,971 473,971 Office equipment 30,902 30,902 Furniture and fixtures 6,495 6,495 Equipment and machinery 1,828,006 423,547 Fixed assets, gross 2,477,622 1,073,163 Less: accumulated depreciation (92,484 ) (84,627 ) Total $ 2,385,138 $ 988,536 Depreciation and amortization expense totaled $ 7,857 12,485

Accrued Expenses

Accrued Expenses	3 Months Ended
	Mar. 31, 2023
Payables and Accruals [Abstract]
Accrued Expenses	Note 9 – Accrued Expenses Accrued expenses consisted of the following at March 31, 2023 and December 31, 2022, respectively: Schedule of Accrued Expenses March 31, December 31, 2023 2022 Accrued payroll $ 757,086 $ 613,569 Accrued withholding taxes and employee benefits 34,336 31,632 Accrued ICA fees and contributions 156,205 167,037 Accrued interest 172,098 136,220 Accrued expenses $ 1,119,725 $ 948,458

Deferred Revenues

Deferred Revenues	3 Months Ended
	Mar. 31, 2023
Deferred Revenues
Deferred Revenues	Note 10 – Deferred Revenues Arrangements with customers include multiple deliverables, consisting of an initial delivery of seeds and a contingent portion of the purchase price that is payable on the customer’s future harvest of the plants grown from such seeds. Deferred revenues associated with these multiple-element arrangements were $ 10,114 11,808 5,923 6,655 4,191 5,153

Leases

Leases	3 Months Ended
	Mar. 31, 2023
Leases
Leases	Note 11 – Leases The Company leased its 12,400 57,339,000 15,290 7,700 20,148 On October 1, 2022, the Company entered into a five-year non-cancelable property lease, with an automatic five year extension, for a new extraction facility with combined office space, at a monthly lease term of 29,000,000 6,300 2 The Company also leases a residential premise under a non-cancelable real property lease agreement that commenced on September 1, 2021 and expires on August 31, 2024, at a monthly lease term of 3,800,000 1,013 3 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) The Company leases another residential premise under a non-cancelable real property lease agreement that commenced on June 1, 2022 and expires on May 30, 2024, at a monthly lease term of 1,900,000 507 8 In addition, the Company leases its corporate offices and operational facility in Colombia under short-term non-cancelable real property lease agreements that expire within a year. The Company doesn’t have any other office or equipment leases that would require capitalization. The office lease contains provisions requiring payment of property taxes, utilities, insurance, maintenance and other occupancy costs applicable to the leased premise. In the locations in which it is economically feasible to continue to operate, management expects to enter into a new lease upon expiration. The extraction facility lease contained provisions requiring payment of property taxes, utilities, insurance, maintenance and other occupancy costs applicable to the leased premise. As the Company’s leases do not provide implicit discount rates, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The components of lease expense were as follows: Schedule of Components of Lease Expense 2023 2022 For the Three Months Ended March 31, 2023 2022 Operating lease cost: Amortization of right-of-use assets $ 22,242 $ 33,431 Interest on lease liabilities 7,105 26,463 Lease payments on short term leases - 12,590 Total operating lease cost $ 29,347 $ 72,484 Supplemental balance sheet information related to leases was as follows: Schedule of Supplemental Balance Sheet Information Related to Leases March 31, December 31, 2023 2022 Operating lease: Operating lease assets $ 403,727 $ 425,969 Current portion of operating lease liabilities $ 88,612 86,235 Noncurrent operating lease liabilities 318,556 341,680 Total operating lease liability $ 407,168 $ 427,915 Weighted average remaining lease term: Operating leases 4 4.25 Weighted average discount rate: Operating lease 6.75 % 6.75 % ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) Supplemental cash flow and other information related to operating leases was as follows: Schedule of Supplemental Cash Flow Related to Operating Leases 2023 2022 For the Three Months Ended March 31, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used for operating leases $ 20,747 $ 26,497 Leased assets obtained in exchange for lease liabilities: Total operating lease liabilities $ - $ 1,535,706 Future minimum annual lease commitments under non-cancelable operating leases are as follows at March 31, 2023: Schedule of Operating Lease Liability Maturity Operating Leases 2023 (for the nine months remaining) $ 84,656 2024 107,632 2025 99,186 2026 102,162 2027 78,336 Total minimum lease payments 471,972 Less interest 64,804 Present value of lease liabilities 407,168 Less current portion 88,612 Long-term lease liabilities $ 318,556

Convertible Notes Payable

Convertible Notes Payable	3 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
Convertible Notes Payable	Note 12 – Convertible Notes Payable Convertible notes payable consists of the following at March 31, 2023 and December 31, 2022, respectively: Schedule of Convertible Note Payable March 31, December 31, 2023 2022 On September 27, 2022, $ 750,000 $ 750,000 On September 27, 2022, the Company completed the sale of a Convertible Promissory Note in the principal amount of $ 750,000 8 15 $ 750,000 $ 750,000 Total convertible notes payable 750,000 750,000 Less: unamortized debt discounts - - Convertible note payable, net of discounts $ 750,000 $ 750,000 The Company recorded interest expense pursuant to the stated interest rates on the convertible note in the amount of $ 14,795 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Notes Payable

Notes Payable	3 Months Ended
	Mar. 31, 2023
Notes Payable
Notes Payable	Note 13 – Notes Payable Schedule of Notes Payable March 31, December 31, 2023 2022 On September 15, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received proceeds of 55,488,000 12,243 70,000,000 15,445 4 3,202 317 $ 15,128 $ 14,552 On June 17, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received proceeds of 230,400,000 55,821 240,000,000 58,147 4 2,326 3,955 51,866 49,894 On June 13, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 January 1, 2024 8 100,000 100,000 On May 31, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received proceeds of 314,640,000 76,231 360,000,000 87,220 2.1 10,990 9,420 77,800 74,841 On May 30, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received a non-interest bearing loan of 20,000,000 4,846 524 4,322 4,158 On April 29, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received a non-interest bearing loan of 10,000,000 2,423 262 2,161 2,079 On March 1, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 400,000 January 1, 2024 8 400,000 400,000 On February 15, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 200,000 January 1, 2024 8 200,000 200,000 Total notes payable 851,277 845,524 Less: current maturities 151,277 145,524 Notes payable, long-term portion $ 700,000 $ 700,000 The Company recorded interest expense pursuant to the stated interest rates on the notes payable in the amount of $ 37,808 3,888 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Notes Payable, Related Party

Notes Payable, Related Party	3 Months Ended
	Mar. 31, 2023
Notes Payable Related Party
Notes Payable, Related Party	Note 14 – Notes Payable, Related Party Notes payable, related party, consists of the following at March 31, 2023 and December 31, 2022, respectively: Schedule of Notes Payable Related Party March 31, December 31, 2023 2022 On August 5, 2022, the Company received an advance of $ 50,000 6 $ 50,000 $ 50,000 On August 2, 2022, the Company received an advance of $ 4,500 6 4,500 4,500 On July 7, 2022, the Company received an advance of $ 5,000 6 5,000 5,000 On June 3, 2022, the Company received an advance of $ 10,000 6 10,000 10,000 On May 5, 2022, the Company received an advance of $ 10,000 6 10,000 10,000 On May 5, 2022, the Company received an advance of $ 20,000 6 20,000 20,000 On December 29, 2021, the Company received an advance of $ 200,000 January 1, 2024 8 200,000 200,000 Total notes payable. related party 299,500 299,500 Less: current maturities 99,500 99,500 Notes payable, related party, long-term portion $ 200,000 $ 200,000 The Company recorded interest expense pursuant to the stated interest rates on the notes payable, related party, in the amount of $ 5,467 3,967 The Company recognized interest expense for the three months ended March 31, 2023 and 2022, as follows: Schedule of Interest Expenses March 31, March 31, 2023 2022 Interest on convertible notes $ 14,795 $ 14,795 Interest on notes payable 37,808 3,888 Interest on notes payable, related party 5,467 3,967 Amortization of debt discounts - 17,569 Amortization of debt discounts, common stock - 37,002 Amortization of debt discounts, warrants - 88,278 Interest on accounts payable - 693 Total interest expense $ 58,070 $ 166,192 ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Convertible Preferred Stock

Convertible Preferred Stock	3 Months Ended
	Mar. 31, 2023
Convertible Preferred Stock
Convertible Preferred Stock	Note 15 – Convertible Preferred Stock Preferred Stock The Company has 10,000,000 0.001 500,000 600,000 The Series A Preferred Stock accrues dividends at the rate of 6% 89,733 272,168 10 15 The Series A and B Preferred Stock have been classified outside of permanent equity and liabilities. the Series A Preferred Stock embodies conditional obligations that the Company may settle by issuing a variable number of equity shares, and in both the Series A and B Preferred Stock, monetary value of the obligation is based on a fixed monetary amount known at inception. Series A Preferred Stock Sales On various dates between January 4, 2023 and January 27, 2023, the Company received total proceeds from three accredited investors of $ 150,000 15,000 15,000 five 1,500,000 0.25 Series A Preferred Stock Issued for Services, Consultants On January 1, 2023, the Company issued 4,500 The fair value of the shares was $ 45,000 Preferred Stock Dividends The Series A Preferred Stock accrues dividends at the rate of 6% 12,773 10,258 150,616 Series B Preferred Stock Issuances No

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 16 – Commitments and Contingencies Equity Line of Credit On September 1, 2022, the Company entered into a Purchase Agreement (the “ELOC Purchase Agreement”) with Tysadco Partners, LLC (“Tysadco”). Pursuant to the ELOC Purchase Agreement, Tysadco has agreed to purchase from the Company, from time to time upon delivery by the Company to Tysadco of “Request Notices,” and subject to the other terms and conditions set forth in the ELOC Purchase Agreement, up to an aggregate of $ 10,000,000 The purchase price of the shares of common stock to be purchased under the Purchase Agreement will be equal to 88% of the lowest daily “VWAP” during the period of 10 trading days beginning five trading days preceding the applicable Request. Each purchase under the Purchase Agreement will be in a minimum amount of $25,000 and a maximum amount equal to the lesser of (i) $1,000,000 and (ii) 500% of the average daily trading value of the common stock over the seven trading days preceding the delivery of the applicable Request Notice. In connection with the ELOC Purchase Agreement, the Company entered into a Registration Rights Agreement with Tysadco under which the Company agreed to file a registration statement with the Securities and Exchange Commission covering the shares of common stock issuable under the ELOC Purchase Agreement and conversion of the Commitment Fee Shares (the “Registration Rights Agreement”). There have not been any advances on this arrangement to date. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited) Commitment for the Sale of Series B Preferred Stock On October 3, 2022, the Company and ISIAH International, LLC (“ISIAH International”), an entity in which the Company’s CEO, Isiah L. Thomas, III, is the sole member, entered into a securities purchase agreement under which ISIAH International has agreed to purchase from the Company an aggregate of 33,333 3,333,300 499,995

Changes in Stockholders_ Equity

Changes in Stockholders’ Equity	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Changes in Stockholders’ Equity	Note 17 – Changes in Stockholders’ Equity Common Stock The Company is authorized to issue an aggregate of 300,000,000 0.001 70,202,907 Common Stock Sales On February 14, 2023, the Company sold 3,000,000 0.10 300,000 Amortization of Stock-Based Compensation A total of $ 38,130 41,114

Common Stock Options

Common Stock Options	3 Months Ended
	Mar. 31, 2023
Common Stock Options
Common Stock Options	Note 18 – Common Stock Options Stock Incentive Plan On February 12, 2020, the Company’s stockholders approved our 2019 Stock Incentive Plan (the “2019 Plan”), which had been adopted by the Company’s Board of Directors (the “Board”) as of December 10, 2019. The 2019 Plan provides for the issuance of up to 10,000,000 The Company recognized a total of $ 38,130 41,114 93,897

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Note 19 – Income Taxes The Company accounts for income taxes under FASB ASC 740-10, which requires use of the liability method. FASB ASC 740-10-25 provides that deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes, referred to as temporary differences. For the three months ended March 31, 2023, and the year ended December 31, 2022, the Company incurred a net operating loss and, accordingly, no provision for income taxes has been recorded. In addition, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets. At March 31, 2023, the Company had approximately $ 9,476,000 The net operating loss carry forwards, if not utilized, will begin to expire in 2025 Based on the available objective evidence, including the Company’s history of its loss, management believes it is more likely than not that the net deferred tax assets will not be fully realizable. Accordingly, the Company provided for a full valuation allowance against its net deferred tax assets at March 31, 2023 and December 31, 2022, respectively. In accordance with FASB ASC 740, the Company has evaluated its tax positions and determined there are no uncertain tax positions. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 20 – Subsequent Events The Company evaluates events that have occurred after the balance sheet date through the date these financial statements were issued. Debt Offering & Commitment Fee Stock Issuance On June 23, 2023, the Company completed the sale of a Promissory Note in the principal amount of $ 300,000 276,000 262,500 24,000 7,500 6,000 The Third AJB Note matures on March 23, 2024 12% 10 Pursuant to the Purchase Agreement, the Company paid a commitment fee to AJB Capital in the amount of $ 100,000 1,666,667 121,667 In connection with the issuance of the Third AJB Note and Commitment Fee Shares, the Company entered into a Registration Rights Agreement with AJB Capital in which the Company agreed to file a registration statement with the SEC within 180 days of June 23, 2023, registering the shares of common stock issuable under the Third AJB Note and Purchase Agreement. Series A Preferred Stock Sale On April 3, 2023, the Company received $ 100,000 10,000 10,000 five 1,000,000 0.25 Common Stock Issued for Services On June 15, 2023, the Company issued 1,500,000 The fair value of the shares was $ 89,850

Nature of Business and Signif_2

Nature of Business and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Nature of Business	Nature of Business One World Products, Inc. (the “Company,” “we,” “our” or “us”) was incorporated in Nevada on September 2, 2014. On February 21, 2019, we entered into an Agreement and Plan of Merger with OWP Merger Subsidiary, Inc., our wholly-owned subsidiary, and OWP Ventures, Inc. (“OWP Ventures”), which is the parent company of One World Pharma SAS, a Colombian company (“OWP Colombia”). Pursuant to the Merger Agreement, we acquired OWP Ventures (and indirectly, OWP Colombia) by the merger of OWP Merger Subsidiary with and into OWP Ventures, with OWP Ventures being the surviving entity as our wholly-owned subsidiary (the “Merger”). As a result of the Merger (a) holders of the outstanding capital stock of OWP Ventures received an aggregate of 39,475,398 825,000 0.50 825,000 0.50 300,000 0.424 875,000 n November 23, 2021, the Company changed its name to One World Products, Inc. through the merger of One World Products, Inc., a recently formed Nevada corporation wholly-owned by the Company, with and into the Company (the “Name Change Merger”) pursuant to the applicable provisions of the Nevada Revised Statutes (“NRS”). As permitted by the NRS, the articles of merger filed with the Secretary of State of the state of Nevada to effect the Name Change Merger amended Article I of the Company’s Articles of Incorporation to change the Company’s name to “One World Products, Inc.” The Name Change Merger was effected solely to effect the change of the Company’s name, and had no effect on the Company’s officers, directors, operations, assets or liabilities. OWP Ventures is a holding company formed in Delaware on March 27, 2018 to enter and support the cannabis industry, and on May 30, 2018, it acquired OWP Colombia. OWP Colombia is a licensed cannabis cultivation, production and distribution (export) company located in Popayán, Colombia (nearest major city is Cali). We plan to be a producer of raw cannabis and hemp plant ingredients for both medical and industrial uses across the globe. We have received licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific and industrial purposes. Specifically, we are one of the few companies in Colombia to receive all four licenses, including seed use, cultivation of non-psychoactive cannabis, cultivation of psychoactive cannabis, and manufacturing allowing for extraction and export. Currently, we own approximately 30 acres and have a covered greenhouse built specifically to cultivate high-grade cannabis and hemp. In addition, we have entered into agreements with local farming co-operatives that include small farmers and indigenous tribe members, under which they will cultivate cannabis on up to approximately 140 acres of land using our seeds and propagation techniques, and sell their harvested products to us on an exclusive basis. We began harvesting cannabis in the first quarter of 2019 for the purpose of further research and development activities, quality control testing and extraction. We have been generating revenue from the sale of our seeds since the second quarter of 2020. During the first quarter of 2022, we made payments of approximately $ 1,400,000 5
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and the rules of the Securities and Exchange Commission (SEC). Intercompany accounts and transactions have been eliminated. The unaudited condensed consolidated financial statements of the Company and the accompanying notes included in this Quarterly Report on Form 10-Q are unaudited. In the opinion of management, all adjustments necessary for a fair presentation of the Condensed Consolidated Financial Statements have been included. Such adjustments are of a normal, recurring nature. The Condensed Consolidated Financial Statements, and the accompanying notes, are prepared in accordance with GAAP and do not contain certain information included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The interim Condensed Consolidated Financial Statements should be read in conjunction with that Annual Report on Form 10-K. Results for the interim periods presented are not necessarily indicative of the results that might be expected for the entire fiscal year. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at March 31, 2023: Schedule of Common Control and Ownership Interest State of Name of Entity Incorporation Relationship One World Products, Inc. (1) Nevada Parent OWP Ventures, Inc. (2) Delaware Subsidiary One World Pharma S.A.S (3) Colombia Subsidiary Colombian Hope, S.A.S (4) Colombia Subsidiary Agrobase, S.A.S. (5) Colombia Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc. (3) Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogotá on July 18, 2017. Its headquarters are located in Bogotá. (4) Wholly-owned subsidiary of OWP Ventures, Inc., acquired on November 19, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. (5) Wholly-owned subsidiary of OWP Ventures, Inc., formed on September 12, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. The Company’s headquarters are located in Las Vegas, Nevada and substantially all of its production efforts are within Popayán, Colombia.
Reclassifications	Reclassifications Certain reclassifications have been made to the prior years’ financial statements to conform to current year presentation. These reclassifications had no effect on previously reported results of operations or retained earnings.
Foreign Currency Translation	Foreign Currency Translation The functional currency of the Company is Columbian Peso (COP). The Company has maintained its financial statements using the functional currency, and translated those financial statements to the US Dollar (USD) throughout this report. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income (loss) for the respective periods.
Comprehensive Income	Comprehensive Income The Company has adopted the Financial Accounting Standards Boards (“FASB”) Accounting Standards Codification (“ASC”) 220, Reporting Comprehensive Income, which establishes standards for reporting and displaying comprehensive income, its components, and accumulated balances in a full-set of general-purpose financial statements. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)
Segment Reporting	Segment Reporting ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company discloses the fair value of certain assets and liabilities in accordance with ASC 820 – Fair Value Measurement and Disclosures (ASC 820). Under ASC 820-10-05, the FASB establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. This Statement reaffirms that fair value is the relevant measurement attribute. The adoption of this standard did not have a material effect on the Company’s financial statements as reflected herein. The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses reported on the balance sheets are estimated by management to approximate fair value primarily due to the short-term nature of the instruments.
Cash in Excess of FDIC Insured Limits	Cash in Excess of FDIC Insured Limits The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $ 250,000 not
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. The Company’s sales to date have primarily consisted of the sale of seeds. These sales include multi-element arrangements whereby the Company collects 50% of the sale upon delivery of the sales, and the remaining 50% upon the completion of the harvest, whether the seeds result in a successful crop, or not. In addition, the Company has a right of first refusal to purchase products resulting from the harvest. At March 31, 2023, the Company had $ 10,114 5,923
Inventory	Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our cannabis products consist of cannabis flower grown in-house, along with produced extracts.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for equity instruments issued to employees and non-employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.
Basic and Diluted Loss Per Share	Basic and Diluted Loss Per Share The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the periods presented, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share. ONE WORLD PRODUCTS, INC. Notes to Condensed Consolidated Financial Statements (Unaudited)
Recent Accounting Pronouncements	Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements upon adoption. In October 2021, the FASB issued ASU , Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, The adoption of ASU 2021-08 did not have a material impact on the Company’s financial statements or related disclosures. In May 2021, the FASB issued ASU No. 2021-04, Earnings Per Share Debt – Modifications and Extinguishments Compensation and Derivatives and Hedging – Contracts in Entity’s Own Equity Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity Classified Written Call Options In March 2020, the FASB issued ASU 2020-04 establishing Topic 848, Reference Rate Reform In August 2020, the FASB issued ASU No. 2020-06, Debt–Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging–Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if converted method. The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2021, with early adoption permitted. The adoption of ASU 2020-06 has not had a material impact on the Company’s financial statements or related disclosures. No other new accounting pronouncements, issued or effective during the period ended March 31, 2023, have had or are expected to have a significant impact on the Company’s financial statements.

Nature of Business and Signif_3

Nature of Business and Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Schedule of Common Control and Ownership Interest	The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at March 31, 2023: Schedule of Common Control and Ownership Interest State of Name of Entity Incorporation Relationship One World Products, Inc. (1) Nevada Parent OWP Ventures, Inc. (2) Delaware Subsidiary One World Pharma S.A.S (3) Colombia Subsidiary Colombian Hope, S.A.S (4) Colombia Subsidiary Agrobase, S.A.S. (5) Colombia Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc. (3) Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogotá on July 18, 2017. Its headquarters are located in Bogotá. (4) Wholly-owned subsidiary of OWP Ventures, Inc., acquired on November 19, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. (5) Wholly-owned subsidiary of OWP Ventures, Inc., formed on September 12, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses.

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2023
Investments, All Other Investments [Abstract]
Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis	The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheet as of March 31, 2023 and December 31, 2022, respectively: Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis Level 1 Level 2 Level 3 Fair Value Measurements at March 31, 2023 Level 1 Level 2 Level 3 Assets Cash $ 84,709 $ - $ - Right-of-use asset - - 403,727 Total assets 84,709 - 403,727 Liabilities Lease liabilities - - 407,168 Convertible notes payable - 750,000 - Notes payable - 851,277 - Notes payable, related parties - 299,500 - Total liabilities - (1,900,777 ) (407,168 ) Total assets and liabilities $ 84,709 $ (1,900,777 ) $ (3,441 ) Level 1 Level 2 Level 3 Fair Value Measurements at December 31, 2022 Level 1 Level 2 Level 3 Assets Cash $ 11,016 $ - $ - Right-of-use asset - - 425,969 Total assets 11,016 - 425,969 Liabilities Lease liabilities - 427,915 Convertible notes payable - 750,000 - Notes payable - 845,524 - Notes payable, related parties - 299,500 - Total liabilities - (1,895,024 ) (427,915 ) Total assets and liabilities $ 11,016 $ (1,895,024 ) $ (1,946 )

Inventory (Tables)

Inventory (Tables)	3 Months Ended
	Mar. 31, 2023
Inventory Disclosure [Abstract]
Schedule of Inventory	Schedule of Inventory March 31, December 31, 2023 2022 Raw materials $ 19,215 $ 18,580 Work in progress 37,059 1,464 Finished goods 271,513 80,858 Inventory gross 327,787 100,902 Less obsolescence (48,597 ) (46,749 ) Total inventory $ 279,190 $ 54,153

Other Current Assets (Tables)

Other Current Assets (Tables)	3 Months Ended
	Mar. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Current Assets	Other current assets included the following as of March 31, 2023 and December 31, 2022, respectively: Schedule of Other Current Assets March 31, December 31, 2023 2022 Prepaid expenses $ 67,373 $ 39,288 Deferred cost of goods sold 5,923 6,655 Total $ 73,296 $ 45,943

Security Deposits (Tables)

Security Deposits (Tables)	3 Months Ended
	Mar. 31, 2023
Security Deposits
Schedule of Security Deposits	Security deposits included the following as of March 31, 2023 and December 31, 2022, respectively: Schedule of Security Deposits March 31, December 31, 2023 2022 Refundable deposit on equipment purchase $ 50,000 $ 50,000 Down payment on distillation equipment - 1,399,413 Security deposits on leases held in Colombia 411 395 Security deposits $ 50,411 $ 1,449,808

Fixed Assets (Tables)

Fixed Assets (Tables)	3 Months Ended
	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Schedule of Fixed Assets	Fixed assets consist of the following at March 31, 2023 and December 31, 2022, respectively: Schedule of Fixed Assets March 31, December 31, 2023 2022 Land $ 138,248 $ 138,248 Buildings 473,971 473,971 Office equipment 30,902 30,902 Furniture and fixtures 6,495 6,495 Equipment and machinery 1,828,006 423,547 Fixed assets, gross 2,477,622 1,073,163 Less: accumulated depreciation (92,484 ) (84,627 ) Total $ 2,385,138 $ 988,536

Accrued Expenses (Tables)

Accrued Expenses (Tables)	3 Months Ended
	Mar. 31, 2023
Payables and Accruals [Abstract]
Schedule of Accrued Expenses	Accrued expenses consisted of the following at March 31, 2023 and December 31, 2022, respectively: Schedule of Accrued Expenses March 31, December 31, 2023 2022 Accrued payroll $ 757,086 $ 613,569 Accrued withholding taxes and employee benefits 34,336 31,632 Accrued ICA fees and contributions 156,205 167,037 Accrued interest 172,098 136,220 Accrued expenses $ 1,119,725 $ 948,458

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2023
Leases
Schedule of Components of Lease Expense	The components of lease expense were as follows: Schedule of Components of Lease Expense 2023 2022 For the Three Months Ended March 31, 2023 2022 Operating lease cost: Amortization of right-of-use assets $ 22,242 $ 33,431 Interest on lease liabilities 7,105 26,463 Lease payments on short term leases - 12,590 Total operating lease cost $ 29,347 $ 72,484
Schedule of Supplemental Balance Sheet Information Related to Leases	Supplemental balance sheet information related to leases was as follows: Schedule of Supplemental Balance Sheet Information Related to Leases March 31, December 31, 2023 2022 Operating lease: Operating lease assets $ 403,727 $ 425,969 Current portion of operating lease liabilities $ 88,612 86,235 Noncurrent operating lease liabilities 318,556 341,680 Total operating lease liability $ 407,168 $ 427,915 Weighted average remaining lease term: Operating leases 4 4.25 Weighted average discount rate: Operating lease 6.75 % 6.75 %
Schedule of Supplemental Cash Flow Related to Operating Leases	Supplemental cash flow and other information related to operating leases was as follows: Schedule of Supplemental Cash Flow Related to Operating Leases 2023 2022 For the Three Months Ended March 31, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used for operating leases $ 20,747 $ 26,497 Leased assets obtained in exchange for lease liabilities: Total operating lease liabilities $ - $ 1,535,706
Schedule of Operating Lease Liability Maturity	Future minimum annual lease commitments under non-cancelable operating leases are as follows at March 31, 2023: Schedule of Operating Lease Liability Maturity Operating Leases 2023 (for the nine months remaining) $ 84,656 2024 107,632 2025 99,186 2026 102,162 2027 78,336 Total minimum lease payments 471,972 Less interest 64,804 Present value of lease liabilities 407,168 Less current portion 88,612 Long-term lease liabilities $ 318,556

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
Schedule of Convertible Note Payable	Convertible notes payable consists of the following at March 31, 2023 and December 31, 2022, respectively: Schedule of Convertible Note Payable March 31, December 31, 2023 2022 On September 27, 2022, $ 750,000 $ 750,000 On September 27, 2022, the Company completed the sale of a Convertible Promissory Note in the principal amount of $ 750,000 8 15 $ 750,000 $ 750,000 Total convertible notes payable 750,000 750,000 Less: unamortized debt discounts - - Convertible note payable, net of discounts $ 750,000 $ 750,000

Notes Payable (Tables)

Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2023
Notes Payable
Schedule of Notes Payable	Schedule of Notes Payable March 31, December 31, 2023 2022 On September 15, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received proceeds of 55,488,000 12,243 70,000,000 15,445 4 3,202 317 $ 15,128 $ 14,552 On June 17, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received proceeds of 230,400,000 55,821 240,000,000 58,147 4 2,326 3,955 51,866 49,894 On June 13, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 January 1, 2024 8 100,000 100,000 On May 31, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received proceeds of 314,640,000 76,231 360,000,000 87,220 2.1 10,990 9,420 77,800 74,841 On May 30, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received a non-interest bearing loan of 20,000,000 4,846 524 4,322 4,158 On April 29, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received a non-interest bearing loan of 10,000,000 2,423 262 2,161 2,079 On March 1, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 400,000 January 1, 2024 8 400,000 400,000 On February 15, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 200,000 January 1, 2024 8 200,000 200,000 Total notes payable 851,277 845,524 Less: current maturities 151,277 145,524 Notes payable, long-term portion $ 700,000 $ 700,000

Notes Payable, Related Party (T

Notes Payable, Related Party (Tables)	3 Months Ended
	Mar. 31, 2023
Notes Payable Related Party
Schedule of Notes Payable Related Party	Notes payable, related party, consists of the following at March 31, 2023 and December 31, 2022, respectively: Schedule of Notes Payable Related Party March 31, December 31, 2023 2022 On August 5, 2022, the Company received an advance of $ 50,000 6 $ 50,000 $ 50,000 On August 2, 2022, the Company received an advance of $ 4,500 6 4,500 4,500 On July 7, 2022, the Company received an advance of $ 5,000 6 5,000 5,000 On June 3, 2022, the Company received an advance of $ 10,000 6 10,000 10,000 On May 5, 2022, the Company received an advance of $ 10,000 6 10,000 10,000 On May 5, 2022, the Company received an advance of $ 20,000 6 20,000 20,000 On December 29, 2021, the Company received an advance of $ 200,000 January 1, 2024 8 200,000 200,000 Total notes payable. related party 299,500 299,500 Less: current maturities 99,500 99,500 Notes payable, related party, long-term portion $ 200,000 $ 200,000
Schedule of Interest Expenses	The Company recognized interest expense for the three months ended March 31, 2023 and 2022, as follows: Schedule of Interest Expenses March 31, March 31, 2023 2022 Interest on convertible notes $ 14,795 $ 14,795 Interest on notes payable 37,808 3,888 Interest on notes payable, related party 5,467 3,967 Amortization of debt discounts - 17,569 Amortization of debt discounts, common stock - 37,002 Amortization of debt discounts, warrants - 88,278 Interest on accounts payable - 693 Total interest expense $ 58,070 $ 166,192

Schedule of Common Control and

Schedule of Common Control and Ownership Interest (Details)	3 Months Ended
	Mar. 31, 2023
Name of entity	ONE WORLD PRODUCTS, INC.
State of incorporation	NV
One World Products, Inc. [Member]
Name of entity	One World Products, Inc.	[1]
State of incorporation	NV
Relationship	Parent
OWP Ventures, Inc. [Member]
Name of entity	OWP Ventures, Inc.	[2]
State of incorporation	DE
Relationship	Subsidiary
One World Pharma S.A.S. [Member]
Name of entity	One World Pharma S.A.S	[3]
State of incorporation	F8
Relationship	Subsidiary
Colombian Hope, S.A.S. [Member]
Name of entity	Colombian Hope, S.A.S	[4]
State of incorporation	F8
Relationship	Subsidiary
Agrobase, S.A.S. [Member]
Name of entity	Agrobase, S.A.S.	[5]
State of incorporation	F8
Relationship	Subsidiary
[1]Holding company in the form of a corporation.[2]Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc.[3]Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogotá on July 18, 2017. Its headquarters are located in Bogotá.[4]Wholly-owned subsidiary of OWP Ventures, Inc., acquired on November 19, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses.[5]Wholly-owned subsidiary of OWP Ventures, Inc., formed on September 12, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses.

Nature of Business and Signif_4

Nature of Business and Significant Accounting Policies (Details Narrative) - USD ($)		3 Months Ended
	Feb. 21, 2019	Mar. 31, 2023	Dec. 31, 2022	Oct. 01, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Lease term				5 years
FDIC insured amount		$ 250,000
Cash uninsured amount
Deferred revenue		10,114	$ 11,808
Deferred revenue cost of goods sold		5,923	$ 6,655
Merger Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Options to purchase common stock	825,000
Common stock exercise price	$ 0.50
Merger Agreement [Member] | OWP Ventures, Inc. [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of stock issued	39,475,398
Options to purchase common stock	825,000
Common stock exercise price	$ 0.50
Proceeds from issuance convertible note	$ 300,000
Conversion price	$ 0.424
Number of shares cancelled	875,000
Payment for machinery		$ 1,400,000

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash on hand	$ 84,709	$ 11,016
Working capital	2,669,690
Accumulated deficit	$ 23,492,303	$ 22,976,365

Schedule of Valuation of Financ

Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Assets
Right-of-use asset	$ 403,727	$ 425,969
Liabilities
Lease liabilities	407,168	427,915
Fair Value, Inputs, Level 1 [Member]
Assets
Cash	84,709	11,016
Right-of-use asset
Total assets	84,709	11,016
Liabilities
Lease liabilities
Convertible notes payable
Notes payable
Notes payable, related parties
Total liabilities
Total assets and liabilities	84,709	11,016
Fair Value, Inputs, Level 2 [Member]
Assets
Cash
Right-of-use asset
Total assets
Liabilities
Lease liabilities
Convertible notes payable	750,000	750,000
Notes payable	851,277	845,524
Notes payable, related parties	299,500	299,500
Total liabilities	(1,900,777)	(1,895,024)
Total assets and liabilities	(1,900,777)	(1,895,024)
Fair Value, Inputs, Level 3 [Member]
Assets
Cash
Right-of-use asset	403,727	425,969
Total assets	403,727	425,969
Liabilities
Lease liabilities	407,168	427,915
Convertible notes payable
Notes payable
Notes payable, related parties
Total liabilities	(407,168)	(427,915)
Total assets and liabilities	$ (3,441)	$ (1,946)

Schedule of Inventory (Details)

Schedule of Inventory (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 19,215	$ 18,580
Work in progress	37,059	1,464
Finished goods	271,513	80,858
Inventory gross	327,787	100,902
Less obsolescence	(48,597)	(46,749)
Total inventory	$ 279,190	$ 54,153

Schedule of Other Current Asset

Schedule of Other Current Assets (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid expenses	$ 67,373	$ 39,288
Deferred cost of goods sold	5,923	6,655
Total	$ 73,296	$ 45,943

Other Assets (Details Narrative

Other Assets (Details Narrative) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other assets	$ 186,950	$ 179,927

Schedule of Security Deposits (

Schedule of Security Deposits (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Security deposits	$ 50,411	$ 1,449,808
Refundable Deposit on Equipment Purchase [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Security deposits	50,000	50,000
Down Payment on Distillation Equipment [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Security deposits		1,399,413
Security Deposits on Leases Held in Colombia [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Security deposits	$ 411	$ 395

Schedule of Fixed Assets (Detai

Schedule of Fixed Assets (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Fixed assets, gross	$ 2,477,622	$ 1,073,163
Less: accumulated depreciation	(92,484)	(84,627)
Total	2,385,138	988,536
Land [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	138,248	138,248
Building [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	473,971	473,971
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	30,902	30,902
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	6,495	6,495
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	$ 1,828,006	$ 423,547

Fixed Assets (Details Narrative

Fixed Assets (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Depreciation and amortization expense	$ 7,857	$ 12,485

Schedule of Accrued Expenses (D

Schedule of Accrued Expenses (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued payroll	$ 757,086	$ 613,569
Accrued withholding taxes and employee benefits	34,336	31,632
Accrued ICA fees and contributions	156,205	167,037
Accrued interest	172,098	136,220
Accrued expenses	$ 1,119,725	$ 948,458

Deferred Revenues (Details Narr

Deferred Revenues (Details Narrative) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Deferred Revenues
Contract with customer, liability, current	$ 10,114	$ 11,808
Contract with customer, asset, after allowance for credit loss, current	5,923	6,655
Deferred revenue gross	$ 4,191	$ 5,153

Schedule of Components of Lease

Schedule of Components of Lease Expense (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating lease cost:
Amortization of right-of-use assets	$ 22,242	$ 33,431
Interest on lease liabilities	7,105	26,463
Lease payments on short term leases		12,590
Total operating lease cost	$ 29,347	$ 72,484

Schedule of Supplemental Balanc

Schedule of Supplemental Balance Sheet Information Related to Leases (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Leases
Operating lease assets	$ 403,727	$ 425,969
Current portion of operating lease liabilities	88,612	86,235
Noncurrent operating lease liabilities	318,556	341,680
Total operating lease liabilities	$ 407,168	$ 427,915
Weighted average remaining lease term	4 years	4 years 3 months
Weighted average discount rate: operating leases	6.75%	6.75%

Schedule of Supplemental Cash F

Schedule of Supplemental Cash Flow Related to Operating Leases (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Leases
Operating cash flows used for operating leases	$ 20,747	$ 26,497
Total operating lease liabilities		$ 1,535,706

Schedule of Operating Lease Lia

Schedule of Operating Lease Liability Maturity (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Leases
2023 (for the nine months remaining)	$ 84,656
2024	107,632
2025	99,186
2026	102,162
2027	78,336
Total minimum lease payments	471,972
Less interest	64,804
Present value of lease liabilities	407,168	$ 427,915
Less current portion	88,612	86,235
Long-term lease liabilities	$ 318,556	$ 341,680

Leases (Details Narrative)

Leases (Details Narrative)									3 Months Ended	12 Months Ended
	Oct. 01, 2022 USD ($)	Oct. 01, 2022 COP ($)	Jun. 01, 2022 USD ($)	Jun. 01, 2022 COP ($)	Jan. 02, 2022 USD ($) ft²	Jan. 02, 2022 COP ($) ft²	Sep. 01, 2021 USD ($)	Sep. 01, 2021 COP ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Leases
Square foot leased | ft²					12,400	12,400
Monthly lease payment	$ 6,300		$ 507	$ 1,900,000	$ 15,290	$ 57,339,000	$ 1,013	$ 3,800,000
Lease termination fees									$ 7,700
Gain on extinguishment										$ 20,148
VAT and administration fees		$ 29,000,000
Annual escalation of lease payment, percentage	2%	2%	8%	8%			3%	3%

Schedule of Convertible Note Pa

Schedule of Convertible Note Payable (Details) - Convertible Debt [Member] - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Short-Term Debt [Line Items]
Total convertible notes payable	$ 750,000	$ 750,000
Debt instrument, unamortized discount
Notes payable, net of discounts	750,000	750,000
Promissory Note [Member]
Short-Term Debt [Line Items]
Total convertible notes payable	$ 750,000	$ 750,000

Schedule of Convertible Note _2

Schedule of Convertible Note Payable (Details) (Parenthetical) - Promissory Note [Member] - John McCabe Investments LLC [Member]	Sep. 27, 2022 USD ($) $ / shares
Short-Term Debt [Line Items]
Debt instrument, face value | $	$ 750,000
Debt interest rate	8%
Series B Common Stock [Member]
Short-Term Debt [Line Items]
Warrants exercise price | $ / shares	$ 15

Convertible Notes Payable (Deta

Convertible Notes Payable (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Short-Term Debt [Line Items]
Interest expense	$ 14,795	$ 14,795
Convertible Debt [Member]
Short-Term Debt [Line Items]
Interest expense	$ 14,795	$ 14,795

Schedule of Notes Payable (Deta

Schedule of Notes Payable (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Short-Term Debt [Line Items]
Total notes payable	$ 851,277	$ 845,524
Less: current maturities	151,277	145,524
Notes payable, long-term portion	700,000	700,000
Unsecured Promissory Note One [Member]
Short-Term Debt [Line Items]
Total notes payable	15,128	14,552
Unsecured Promissory Note Two [Member]
Short-Term Debt [Line Items]
Total notes payable	51,866	49,894
Unsecured Promissory Note Three [Member]
Short-Term Debt [Line Items]
Total notes payable	100,000	100,000
Unsecured Promissory Note Four [Member]
Short-Term Debt [Line Items]
Total notes payable	77,800	74,841
Unsecured Promissory Note Five [Member]
Short-Term Debt [Line Items]
Total notes payable	4,322	4,158
Unsecured Promissory Note Six [Member]
Short-Term Debt [Line Items]
Total notes payable	2,161	2,079
Unsecured Promissory Note Seven [Member]
Short-Term Debt [Line Items]
Total notes payable	400,000	400,000
Unsecured Promissory Note Eight [Member]
Short-Term Debt [Line Items]
Total notes payable	$ 200,000	$ 200,000

Schedule of Notes Payable (De_2

Schedule of Notes Payable (Details) (Parenthetical)

Sep. 15, 2022 USD ($)

Sep. 15, 2022 COP ($)

Jun. 17, 2022 USD ($)

Jun. 17, 2022 COP ($)

Jun. 13, 2022 USD ($)

May 31, 2022 USD ($)

May 31, 2022 COP ($)

May 30, 2022 USD ($)

Apr. 29, 2022 USD ($)

Mar. 01, 2022 USD ($)

Sep. 15, 2022 COP ($)

Jun. 17, 2022 COP ($)

May 31, 2022 COP ($)

May 30, 2022 COP ($)

Apr. 29, 2022 COP ($)

Feb. 15, 2022 USD ($)

Unsecured Promissory Note One [Member] | One World Pharma S.A.S. [Member]

Short-Term Debt [Line Items]

Proceeds from subsidiary

$ 12,243

$ 55,488,000

Face value

$ 15,445

$ 70,000,000

Debt interest rate

4%

4%

Debt discount

$ 3,202

Foreign currency translation adjustment

$ 317

Unsecured Promissory Note Two [Member] | One World Pharma S.A.S. [Member]

Short-Term Debt [Line Items]

Proceeds from subsidiary

$ 55,821

$ 230,400,000

Face value

$ 58,147

$ 240,000,000

Debt interest rate

4%

4%

Debt discount

$ 2,326

Foreign currency translation adjustment

$ 3,955

Unsecured Promissory Note Three [Member] | OWP Ventures, Inc. [Member]

Short-Term Debt [Line Items]

Face value

$ 100,000

Debt interest rate

8%

Advance, repayment date

Jan. 01, 2024

Unsecured Promissory Note Four [Member] | One World Pharma S.A.S. [Member]

Short-Term Debt [Line Items]

Proceeds from subsidiary

$ 76,231

$ 314,640,000

Face value

$ 87,220

$ 360,000,000

Debt interest rate

2.10%

2.10%

Debt discount

$ 10,990

Foreign currency translation adjustment

$ 9,420

Unsecured Promissory Note Five [Member] | One World Pharma S.A.S. [Member]

Short-Term Debt [Line Items]

Face value

$ 4,846

$ 20,000,000

Foreign currency translation adjustment

$ 524

Unsecured Promissory Note Six [Member] | One World Pharma S.A.S. [Member]

Short-Term Debt [Line Items]

Face value

$ 2,423

$ 10,000,000

Foreign currency translation adjustment

$ 262

Unsecured Promissory Note Seven [Member] | One World Pharma S.A.S. [Member]

Short-Term Debt [Line Items]

Face value

$ 400,000

Debt interest rate

8%

Advance, repayment date

Jan. 01, 2024

Unsecured Promissory Note Eight [Member] | One World Pharma S.A.S. [Member]

Short-Term Debt [Line Items]

Face value

$ 200,000

Debt interest rate

8%

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Notes Payable
Interest expense	$ 37,808	$ 3,888

Schedule of Notes Payable Relat

Schedule of Notes Payable Related Party (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Short-Term Debt [Line Items]
Total notes payable. related party	$ 851,277	$ 845,524
Less: current maturities	151,277	145,524
Notes payable, related party, long-term portion	700,000	700,000
Related Party [Member]
Short-Term Debt [Line Items]
Less: current maturities	99,500	99,500
Notes payable, related party, long-term portion	200,000	200,000
Unsecured Promissory Note One [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	15,128	14,552
Unsecured Promissory Note One [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	50,000	50,000
Unsecured Promissory Note Two [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	51,866	49,894
Unsecured Promissory Note Two [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	4,500	4,500
Unsecured Promissory Note Three [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	100,000	100,000
Unsecured Promissory Note Three [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	5,000	5,000
Unsecured Promissory Note Four [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	77,800	74,841
Unsecured Promissory Note Four [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	10,000	10,000
Unsecured Promissory Note Five [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	4,322	4,158
Unsecured Promissory Note Five [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	10,000	10,000
Unsecured Promissory Note Six [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	2,161	2,079
Unsecured Promissory Note Six [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	20,000	20,000
Unsecured Promissory Note Seven [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	400,000	400,000
Unsecured Promissory Note Seven [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	200,000	200,000
Unsecured Promissory Notes [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	$ 299,500	$ 299,500

Schedule of Notes Payable Rel_2

Schedule of Notes Payable Related Party (Details) (Parenthetical) - Unsecured Promissory Note [Member] - USD ($)	Dec. 29, 2021	Aug. 05, 2022	Aug. 02, 2022	Jul. 07, 2022	Jun. 03, 2022	May 05, 2022
Dr.Kenneth Perego II [Member]
Short-Term Debt [Line Items]
Debt instrument, face value	$ 200,000	$ 50,000		$ 5,000		$ 20,000
Debt interest rate, percentage	8%	6%		6%		6%
Debt Instrument, Maturity Date	Jan. 01, 2024
Isiah Thomas III [Member]
Short-Term Debt [Line Items]
Debt instrument, face value			$ 4,500		$ 10,000	$ 10,000
Debt interest rate, percentage			6%		6%	6%

Schedule of Interest Expenses (

Schedule of Interest Expenses (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Notes Payable Related Party
Interest on convertible notes	$ 14,795	$ 14,795
Interest on notes payable	37,808	3,888
Interest on notes payable, related party	5,467	3,967
Amortization of debt discounts		17,569
Amortization of debt discounts, common stock		37,002
Amortization of debt discounts, warrants		88,278
Interest on accounts payable		693
Total interest expense	$ 58,070	$ 166,192

Notes Payable, Related Party (D

Notes Payable, Related Party (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Related Party Transaction [Line Items]
Interest expense	$ 58,070	$ 166,192
Related Party [Member]
Related Party Transaction [Line Items]
Interest expense	$ 5,467	$ 3,967

Convertible Preferred Stock (De

Convertible Preferred Stock (Details Narrative) - USD ($)				3 Months Ended
	Feb. 14, 2023	Jan. 04, 2023	Jan. 01, 2023	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Preferred stock, shares authorized				9,200,000		9,200,000
Preferred stock, par value				$ 0.001		$ 0.001
Number of stock sold, shares	3,000,000
Series A preferred stock issued for services, consultants
Preferred stock dividend recognized				$ 12,773	$ 10,258
Series A Convertible Preferred Stock [Member]
Preferred stock, shares authorized				10,000,000
Preferred stock, par value				$ 0.001		$ 0.001
Preferred stock shares designated				500,000
Conversion of preferred stock into common stock, description				The Series A Preferred Stock accrues dividends at the rate of 6% per annum, payable in cash as and when declared by the Board or upon a liquidation.
Dividend rate percentage				6%
Series A convertible preferred stock, issued				89,733		70,233
Series A convertible preferred stock, outstanding				89,733		70,233
Series B Convertible Preferred Stock [Member]
Preferred stock, par value				$ 0.001		$ 0.001
Preferred stock shares designated				600,000
Series A convertible preferred stock, issued				272,168		272,168
Series A convertible preferred stock, outstanding				272,168		272,168
Series A Preferred Stock [Member]
Dividend rate percentage				6%
Preferred stock, par value				$ 10
Number of stock sold, shares		15,000
Series B preferred stock issuances			4,500
Series A preferred stock issued for services, consultants			$ 45,000
Dividends, Preferred Stock, Cash				$ 150,616
Series A Preferred Stock [Member] | Preferred Stock Sales [Member]
Proceeds from sale of stock		$ 150,000
Number of stock sold, shares		15,000
Warrant term		5 years
Number of warrants to purchase common stock		1,500,000
Exercise price of warrants		$ 0.25
Series B Preferred Stock [Member]
Preferred stock, par value				$ 15
Series B preferred stock issuances				0

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)			3 Months Ended
	Oct. 03, 2022	Sep. 01, 2022	Mar. 31, 2023
Common stock sold for cash			$ 300,000
Series B Preferred Stock [Member]
Common stock sold for cash	$ 499,995
Common stock sold for cash, shares	3,333,300
Isiah L Thomas III [Member] | Series B Preferred Stock [Member]
Common stock sold for cash, shares	33,333
Common Stock [Member]
Common stock sold for cash			$ 3,000
Common stock sold for cash, shares			3,000,000
Tysadco Partners, LLC [Member] | ELOC Purchase Agreement [Member]
Common stock sold for cash		$ 10,000,000
Tysadco Partners, LLC [Member] | ELOC Purchase Agreement [Member] | Common Stock [Member]
Common stock, conversion basis		The purchase price of the shares of common stock to be purchased under the Purchase Agreement will be equal to 88% of the lowest daily “VWAP” during the period of 10 trading days beginning five trading days preceding the applicable Request. Each purchase under the Purchase Agreement will be in a minimum amount of $25,000 and a maximum amount equal to the lesser of (i) $1,000,000 and (ii) 500% of the average daily trading value of the common stock over the seven trading days preceding the delivery of the applicable Request Notice.

Changes in Stockholders_ Equi_2

Changes in Stockholders’ Equity (Details Narrative) - USD ($)		3 Months Ended
	Feb. 14, 2023	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Equity [Abstract]
Common stock, shares authorized		300,000,000		300,000,000
Common stock, par value		$ 0.001		$ 0.001
Common stock, shares outstanding		70,202,907		67,202,907
Common stock, shares outstanding		70,202,907		67,202,907
Common stock sales	3,000,000
Common stock sales, per share value	$ 0.10
Cash proceeds of common stock sales	$ 300,000	$ 450,000
Amortization of stock-based compensation		$ 38,130	$ 41,114

Common Stock Options (Details N

Common Stock Options (Details Narrative) - USD ($)		3 Months Ended
	Feb. 12, 2020	Mar. 31, 2023	Mar. 31, 2022
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Amortization of stock-based compensation		$ 38,130	$ 41,114
Board of Directors [Member] | 2019 Stock Incentive Plan [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Common stock sold for cash, shares	10,000,000
Officers Directors and Employees [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Unamortized debt issuance expense		$ 93,897

Income Taxes (Details Narrative

Income Taxes (Details Narrative)	3 Months Ended
	Mar. 31, 2023 USD ($)
Income Tax Disclosure [Abstract]
Federal net operating losses	$ 9,476,000
Net operating loss carry forwards expiration	The net operating loss carry forwards, if not utilized, will begin to expire in 2025

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)							3 Months Ended
	Jun. 23, 2023 USD ($) Integer shares	Jun. 15, 2023 USD ($) shares	Apr. 03, 2023 USD ($) $ / shares shares	Feb. 14, 2023 shares	Jan. 04, 2023 USD ($) $ / shares shares	Jan. 01, 2023 USD ($) shares	Mar. 31, 2023 USD ($) shares	Mar. 31, 2022 USD ($) shares
Debt discount								$ 142,849
Number of stock issued for commitment fee amount
Number of stock sold, shares | shares				3,000,000
Common stock shares issued, value							$ 300,000
Common Stock [Member]
Number of stock issued for commitment fee amount								$ 262
Number of stock issued for commitment fee, shares | shares								262,066
Common stock shares issued | shares							3,000,000
Common stock shares issued, value							$ 3,000
Series A Preferred Stock [Member]
Number of stock issued for commitment fee amount						$ 45,000
Number of stock issued for commitment fee, shares | shares						4,500
Number of stock sold, shares | shares					15,000
Series A Preferred Stock [Member] | Preferred Stock Sales [Member]
Proceeds from sale of stock					$ 150,000
Number of stock sold, shares | shares					15,000
Warrant term					5 years
Number of warrants to purchase common stock | shares					1,500,000
Exercise price of warrants | $ / shares					$ 0.25
Subsequent Event [Member] | Mr Joerg Sommer [Member] | Common Stock [Member]
Common stock shares issued | shares		1,500,000
Common stock shares issued, value		$ 89,850
Subsequent Event [Member] | Series A Preferred Stock [Member]
Number of stock sold, shares | shares			10,000
Subsequent Event [Member] | Series A Preferred Stock [Member] | Preferred Stock Sales [Member]
Proceeds from sale of stock			$ 100,000
Number of stock sold, shares | shares			10,000
Warrant term			5 years
Number of warrants to purchase common stock | shares			1,000,000
Exercise price of warrants | $ / shares			$ 0.25
Promissory Note [Member] | AJB Capital Investments LLC [Member] | Subsequent Event [Member]
Debt instrument, face value	$ 300,000
Debt discount	$ 121,667
Debt instrument maturity date	Mar. 23, 2024
Debt interest rate	12%
Trading days | Integer	10
Number of stock issued for commitment fee amount	$ 100,000
Number of stock issued for commitment fee, shares | shares	1,666,667
Promissory Note [Member] | AJB Capital Investments LLC [Member] | Subsequent Event [Member] | Purchase Agreement [Member]
Debt instrument, face value	$ 276,000
Debt discount	262,500
Original issue discount	24,000
Legal fees	7,500
Brokerage fees	$ 6,000